Zogenix, Inc. (ZGNX) PT Lowered to $48 at SVB Leerink Following FDA Refusal to File
Tweet Send to a Friend
SVB Leerink analyst Marc Goodman lowered the price target on Zogenix, Inc. (NASDAQ: ZGNX) to $48.00 (from $60.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
